Utilization of Anti-osteoporosis Drugs in 177 Hospitals of 6 Cities along the Yangtze Valley During 2004～2008
- VernacularTitle:长江流域6城市177家医院2004～2008年抗骨质疏松药利用分析
- Author:
Hong GUO
- Publication Type:Journal Article
- Keywords:
Osteoporosis;
Therapeutic drug;
Consumption sum;
Defined daily dose;
Analysis of utilization
- From:
China Pharmacy
2007;0(29):-
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To probe into the status quo and the tendency of the utilization of the anti-osteoporosis drugs in hospitals along the Yangtze valley. METHODS: The utilization of the anti-osteoporosis drugs in 177 hospitals of 6 cities along the Yangtze valley during 2004～2008 was analyzed statistically in respect of the orders of consumption sum and defined daily dose (DDD). RESULTS: The total amount of the drugs used for osteoporosis in the hospitals of the Yangtze valley showed year-on-year increase,and its proportion in the total remained at around 1.16% on the consumption sum list. The consumption sum of Diphosphonates showed sharp increase,many of its subcategories had forced into the top 10 places on the list of consumption sum and their rankings were moving forward steadily. Alfacalcidol and Calcitonin dominated the first two places over the 5 years. The top 10 manufacturers in terms of the sales sum of the drugs for osteoporosis were mainly foreign investment manufacturers and joint ventures. CONCLUSION: With the aging of the population and the strengthening of public awareness on health,the drugs used for osteoporosis enjoy a potential market,especially to domestic products and domestic manufacturers.
